Citadel Advisors’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.8M Buy
743,734
+612,914
+469% +$12.3M ﹤0.01% 2622
2025
Q4
$2.13M Buy
+130,820
New +$1.98M ﹤0.01% 5787
2025
Q3
Sell
-195,944
Closed -$2.55M 14155
2025
Q2
$2.27M Sell
195,944
-868,322
-82% -$7.92M ﹤0.01% 5467
2025
Q1
$9.29M Sell
1,064,266
-942,092
-47% -$11.9M ﹤0.01% 2958
2024
Q4
$28.8M Sell
2,006,358
-773,612
-28% -$12.2M 0.01% 1788
2024
Q3
$62.8M Buy
2,779,970
+2,445,577
+731% +$50.6M 0.01% 1023
2024
Q2
$6.5M Buy
334,393
+247,234
+284% +$6.47M ﹤0.01% 3363
2024
Q1
$3.27M Sell
87,159
-27,066
-24% -$1.19M ﹤0.01% 4633
2023
Q4
$6.39M Buy
114,225
+98,920
+646% +$4.3M ﹤0.01% 3461
2023
Q3
$631K Sell
15,305
-706,265
-98% -$36.7M ﹤0.01% 7561
2023
Q2
$40.3M Sell
721,570
-508,557
-41% -$27.5M 0.01% 1222
2023
Q1
$68.6M Sell
1,230,127
-233,774
-16% -$10.9M 0.02% 849
2022
Q4
$53.3M Buy
1,463,901
+1,108,820
+312% +$36.3M 0.01% 1076
2022
Q3
$10.1M Buy
355,081
+222,348
+168% +$8.47M ﹤0.01% 2741
2022
Q2
$6.01M Buy
+132,733
New +$6.89M ﹤0.01% 3473
2022
Q1
Sell
-5,616
Closed -$491K 14602
2021
Q4
$837K Sell
5,616
-59,506
-91% -$9.11M ﹤0.01% 8380
2021
Q3
$9.48M Sell
65,122
-10,108
-13% -$1.74M ﹤0.01% 3176
2021
Q2
$14.7M Buy
75,230
+72,604
+2,765% +$13.1M ﹤0.01% 2502
2021
Q1
$475K Sell
2,626
-203,255
-99% -$35.1M ﹤0.01% 9783
2020
Q4
$29.2M Buy
205,881
+89,316
+77% +$13M 0.01% 1420
2020
Q3
$14.5M Buy
116,565
+114,008
+4,459% +$12M ﹤0.01% 1870
2020
Q2
$228K Sell
2,557
-25,504
-91% -$1.99M ﹤0.01% 8342
2020
Q1
$1.75M Buy
28,061
+4,443
+19% +$347K ﹤0.01% 4363
2019
Q4
$1.8M Sell
23,618
-81,852
-78% -$4.92M ﹤0.01% 4582
2019
Q3
$5.32M Buy
+105,470
New +$5.84M ﹤0.01% 3023

Other funds holding TXG